Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/94061
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technologyen_US
dc.creatorKong, Jen_US
dc.creatorZou, Ren_US
dc.creatorLaw, GLen_US
dc.creatorWang, Yen_US
dc.date.accessioned2022-08-11T01:06:48Z-
dc.date.available2022-08-11T01:06:48Z-
dc.identifier.issn2375-2548en_US
dc.identifier.urihttp://hdl.handle.net/10397/94061-
dc.language.isoenen_US
dc.publisherAmerican Association for the Advancement of Science (AAAS)en_US
dc.rightsCopyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC) (https://creativecommons.org/licenses/by-nc/4.0/).en_US
dc.rightsThe following publication Kong, J., Zou, R., Law, G.-L., & Wang, Y. (2022). Biomimetic multifunctional persistent luminescence nanoprobes for long-term near-infrared imaging and therapy of cerebral and cerebellar gliomas. Science Advances, 8(10), eabm7077 is available at https://dx.doi.org/10.1126/sciadv.abm7077.en_US
dc.titleBiomimetic multifunctional persistent luminescence nanoprobes for long-term near-infrared imaging and therapy of cerebral and cerebellar gliomasen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume8en_US
dc.identifier.issue10en_US
dc.identifier.doi10.1126/sciadv.abm7077en_US
dcterms.abstractGlioma is the most common malignant primary brain tumor, and the accurate diagnosis of glioma has always been a challenge. Moreover, cerebellar glioma, which is difficult to be detected by magnetic resonance imaging, is not usually diagnosed until after the appearance of clinical symptoms. In this study, TRZD, a near-infrared (NIR) persistent luminescence (PL) nanoparticle with a dual function of imaging and therapy, was synthesized based on ZnGa2O4:Cr3+,Sn4+. TRZD showed excellent rechargeable NIR PL for more than 30 hours in vivo with good tissue penetration for long-term autofluorescence-free imaging. The tumor growth of both the subcutaneous and orthotropic glioma models was significantly inhibited by TRZD. This is the first-time approach using NIR PL nanoprobes for both diagnosis and therapy of glioma. This is also the first-time report of nanotechnology-based diagnosis and therapy of cerebellar gliomas. This study offers a highly promising multifunctional nanoparticle for theranostics of a wide range of brain diseases.en_US
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationScience advances, 2022, v. 8, no. 10, eabm7077en_US
dcterms.isPartOfScience advancesen_US
dcterms.issued2022-
dc.identifier.scopus2-s2.0-85126078234-
dc.identifier.pmid35263137-
dc.identifier.artneabm7077en_US
dc.description.validate202208 bcrcen_US
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumbera1548-
dc.identifier.SubFormID45390-
dc.description.fundingSourceRGCen_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
sciadv.abm7077.pdf9.25 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

58
Last Week
1
Last month
Citations as of May 12, 2024

Downloads

109
Citations as of May 12, 2024

SCOPUSTM   
Citations

32
Citations as of May 16, 2024

WEB OF SCIENCETM
Citations

27
Citations as of May 16, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.